Article Details
Retrieved on: 2024-05-05 14:17:28
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a new Fraunhofer IPK and FDX Fluid Dynamix GmbH technology, FDmiX, that improves the production of nanoparticles essential for encapsulating mRNA vaccines and other nucleic acid-based medicines, enabling high-quality nanoparticle creation for medical applications like cancer therapy and vaccine development. The tags are directly related to the biotech advancements described in the text.
Article found on: statnano.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here